Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines.
Tesei A, Rosetti M, Ulivi P, Fabbri F, Medri L, Vannini I, Bolla M, Amadori D, Zoli W
J Transl Med 2007, 5:52
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
NO-donating aspirin inhibits angiogenesis by suppressing VEGF expression in HT-29 human colon cancer mouse xenografts.
Ouyang N, Williams JL, Rigas B
Carcinogenesis 2008 Sep, 29:1794-8
 [PubMed Central] [PubMed] [Related articles]
2.
*** Unable to retrieve article 18544566 ***

 [PubMed Central] [PubMed] [Related articles]
3.
NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action.
Rigas B, Williams JL
Nitric Oxide 2008 Sep, 19:199-204
 [PubMed Central] [PubMed] [Related articles]
4.
ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells.
Lee SH, Bahn JH, Choi CK, Whitlock NC, English AE, Safe S, Baek SJ
Mol Cancer Ther 2008 Dec, 7:3739-50
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 1 article in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.